Xiaolei Liu

2.1k citations
95 papers · 1.2k indexed · h-index 20
Topics
Hepatocellular Carcinoma Treatment and Prognosis (12 papers)Vascular Malformations and Hemangiomas (11 papers)Vascular Tumors and Angiosarcomas (9 papers)
Partner nations
ChinaUnited StatesSweden

In The Last Decade

Xiaolei Liu

89 papers receiving 1.2k citations

Peers

Xiaolei Liu
Comparison fields: 5 of 121
  • Molecular Biology 581
  • Surgery 258
  • Epidemiology 196
  • Physiology 180
  • Cancer Research 152
Replace Agnieszka Jasztal with:
Agnieszka Jasztal Poland
Jianjun Zhu China
Akihiro Maeda Japan
Rongxue Wu United States
Zhenyu Wang China
Danchen Wu Canada
Wenbin Zhang China
Kimberly J. Dunham‐Snary Canada
Xiaoyun Li China
Hongming Miao China
Xiaolei Liu relative to Agnieszka Jasztal Poland Agnieszka Jasztal's profile →
Citations per field
00.5×1.5×2.1×
Agnieszka Jasztal · 1×
Citations per year

Countries citing papers authored by Xiaolei Liu

Since Specialization
Citations

This map shows the geographic impact of Xiaolei Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaolei Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaolei Liu more than expected).

Fields of papers citing papers by Xiaolei Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaolei Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaolei Liu. The network helps show where Xiaolei Liu may publish in the future.

Co-authorship network of co-authors of Xiaolei Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaolei Liu. A scholar is included among the top collaborators of Xiaolei Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaolei Liu. Xiaolei Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 3
3 2
4 2
5 1
6 3
7 3
8 3
9 5
10 7
11 4
12 8
13 10
14 21
15 1
16 4
17 6
18 1
19 61
20 1

About Xiaolei Liu

Xiaolei Liu is a scholar working on Hepatology, Surgery and Cancer Research, having authored 95 papers that have together received 1.2k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (12 papers), Vascular Malformations and Hemangiomas (11 papers) and Vascular Tumors and Angiosarcomas (9 papers). The work is most often cited by research in Hepatology (101 citations), Critical Care and Intensive Care Medicine (64 citations) and Cancer Research (152 citations). Xiaolei Liu has collaborated with scholars based in China, United States and Sweden. Frequent co-authors include Bin Jiao, Lu Shen, Zhiying Yang, Yuguang Shi, Haidong Tan, Jia Nie, Shuang Si, Zeneng Cheng, Leonard S. Jefferson and Scot R. Kimball. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature Communications and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026